Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12(4):501–523
Article
Google Scholar
Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26(6):1455–1460
PubMed
PubMed Central
Google Scholar
Ceccon G, Lohmann P, Stoffels G, Judov N, Filss CP, Rapp M et al (2017) Dynamic O-(2–18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy. Neuro Oncol 19(2):281–288
CAS
PubMed
Google Scholar
Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22(4):604–612
CAS
PubMed
PubMed Central
Google Scholar
Dunet V, Rossier C, Buck A, Stupp R, Prior JO (2012) Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and metaanalysis. J Nucl Med 53(2):207–214
Article
CAS
Google Scholar
Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP et al (2007) Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol 28(10):1981–1987
Article
CAS
Google Scholar
Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI et al (2012) Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 53(9):1367–1374
Article
CAS
Google Scholar
Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM et al (2019) PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro Oncol 21(5):585–595
Article
Google Scholar
Galldiks N, Abdulla DSY, Scheffler M, Wolpert F, Werner JM, Hullner M et al (2021) Treatment monitoring of immunotherapy and targeted therapy using (18)F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences. J Nucl Med 62(4):464–470
Article
CAS
Google Scholar
Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217(2):377–384
Article
CAS
Google Scholar
Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48
Article
Google Scholar
Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 26(8):1967–1972
PubMed
PubMed Central
Google Scholar
Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L et al (2005) PET with O-(2–18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results. J Nucl Med 46(3):411–416
CAS
PubMed
Google Scholar
Plotkin M, Eisenacher J, Bruhn H, Wurm R, Michel R, Stockhammer F et al (2004) 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 70(1):49–58
Article
Google Scholar
Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M et al (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54(5):1111–1117 (discussion 7–9)
Article
Google Scholar
Shah AH, Snelling B, Bregy A, Patel PR, Tememe D, Bhatia R et al (2013) Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? J Neurooncol 112(2):141–152
Article
CAS
Google Scholar
Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ et al (2019) Influence of dexamethasone on O-(2-[(18)F]-Fluoroethyl)-L-tyrosine uptake in the human brain and quantification of tumor uptake. Mol Imaging Biol 21(1):168–174
Article
CAS
Google Scholar
Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T et al (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21(5):901–909
CAS
PubMed
PubMed Central
Google Scholar
Sundgren PC, Fan X, Weybright P, Welsh RC, Carlos RC, Petrou M et al (2006) Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 24(9):1131–1142
Article
CAS
Google Scholar
Unterrainer M, Galldiks N, Suchorska B, Kowalew LC, Wenter V, Schmid-Tannwald C et al (2017) (18)F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis. J Nucl Med 58(4):584–589
Article
CAS
Google Scholar